Abstract
Background: Blastocystis spp. is the most common protist detected in human fecal samples in numerous studies globally.Until recently debate regarding its pathogenicity has been controversial. Some studies speculated a possible correlation between Blastocystis and colorectal carcinoma (CRC). No previous studies investigated the presence of non-genotypic differences in Blastocystis spp. isolated from CRC and non-CRC patients. Objectives:The present work aimed to investigate the growth kinetics (GK) and metronidazole (MTZ) sensitivity of Blastocystis isolates from CRC and apparent non-CRC symptomatic and asymptomatic Blastocystis carriers. Materials and Methods: Seven isolates from CRC patients, 6 from symptomatic and 6 from asymptomatic non-CRC carriers were cultured in Locke's Egg (LE) medium supplemented with bovine serum and antibiotic mixture, and incubated at 37°C. Mean viable organisms counts of each isolate were calculated every 24 h to follow their GK. Counts were repeated after exposure to different MTZ concentrations to test their drug sensitivity. Results: In vitro GK of CRC and non-CRC symptomatic isolates were nearly similar at 72 h incubation with apparently higher peaks attained by isolates from CRC patients than the slower growing non-CRC-asymptomatic isolates. MTZ-sensitivity of CRC isolates was nearly similar to that of non-CRC asymptomatic isolates; both were significantly more sensitive than the symptomatic isolates especially at high drug concentration of 200 µg/ml of the medium. Conclusion: The recorded difference in GK and MTZ sensitivity of Blastocystis spp. isolated from different clinical groups suggests the existence of certain biological characters with different pathogenic roles.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.